SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to a significant regulatory catalyst as NOAA modernized deep-sea mining permits, allowing for expedited commercial recovery processes, which TMC immediately leveraged by filing an expanded application. The community is buzzing with bullish sentiment, highlighting growing government recognition of critical deep-sea minerals as a national security priority. This policy shift, combined with high short interest, is fueling discussions around a potential squeeze and long-term value.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending due to significant strategic announcements, including a new post-quantum semiconductor joint venture in India and a potential acquisition of French quantum computing firm Quobly. The community is actively discussing the company's role in the critical and emerging quantum security sector, with many anticipating a short squeeze driven by high trading volume and a strong belief in the stock's long-term potential following recent positive financial updates and analyst upgrades.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals (SXTP) is experiencing extreme volatility following news of a strategic partnership for malaria prevention and a defined significant market opportunity for its babesiosis treatment. This initial surge was swiftly met with a substantial public offering, leading to a sharp decline and fueling intense community debate over potential dilution versus the long-term value of its product pipeline. Traders are closely watching this low-float biotech as bullish enthusiasm clashes with investor caution regarding the offering's impact.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recent $150 million registered direct offering, eliciting strong community debate. While some express concern over dilution, many investors see this capital raise as a vital strategic move to fund accelerated production and potential acquisitions for the burgeoning AI data center market. This move is viewed as institutional validation, positioning POET to capitalize on anticipated major orders with its innovative optical interposer technology.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending after the FDA authorized the use of its first commercially manufactured GP2 drug in the ongoing FLAMINGO-01 trial, a move many perceive as significantly de-risking its path to market for breast cancer recurrence prevention. This catalyst has intensified a passionate debate among investors, with longs highlighting strong insider conviction, a tight share float, and high short interest that could lead to a squeeze, while a vocal contingent anticipates a "sell the news" reaction and further downside.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following a significant licensing deal with Pfizer for its Matrix-M adjuvant, validating the technology as a potential "gold standard" in vaccine development. This partnership, alongside existing deals, is fueling strong community speculation about a massive short squeeze given the substantial short interest. Investors are keenly discussing Matrix-M's broad applicability beyond current vaccines and its advantage as a non-aluminum adjuvant, while urging management to capitalize on this momentum.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending due to reports of an imminent TikTok US spinoff deal, which includes Oracle, fueling speculation about its expanded role in social media data hosting. This development intensifies the ongoing debate among investors regarding Oracle's long-term growth from its significant AI and cloud infrastructure buildouts. The community is actively discussing whether the TikTok news will serve as a strong catalyst for a rebound or if concerns over the company's substantial debt and market skepticism will lead to a "sell the news" reaction.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is generating significant conversation, primarily driven by anticipation for early sales data of its newly launched fibromyalgia drug, Tonmya, and recent investor conferences. A substantial investment by Point72 Asset Management has fueled bullish sentiment, with many discussing its potential to trigger a short squeeze, though historical dilution concerns temper some of the optimism.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending strongly following a productive FDA meeting that outlined a clear pathway for its Anktiva cancer treatment without requiring new trials, fueling significant optimism for its label expansion. This positive development, coupled with accelerating commercial traction and anticipated global approvals, has intensified a robust bullish sentiment, with the community actively discussing a potential short squeeze amidst mounting pressure on those betting against the company's innovative therapies.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is actively trending as the community anticipates a major hyperscaler tenant announcement for its expansive AI data center campus in West Texas, following a key acquisition and strategic partnership. Investors are intensely discussing the potential for a significant short squeeze and drawing comparisons to established data center infrastructure leaders, fueling strong bullish sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
